The ESTIV Members Area
Become member of ESTIV
European Society of Toxicology In Vitro > News > ESTIV and EUSAAT signed a Memorandum of Understanding
1 October 2022

ESTIV and EUSAAT signed a Memorandum of Understanding

The European Society of Toxicology in Vitro (ESTIV) and the European Society for Alternatives to Animal Testing EUSAAT signed a Memorandum of Understanding at the EUSAAT 2022 congress in Linz. The MoU aims to intensify collaboration between the two EU societies with a focus on the implementation of 3Rs and New Approach Methodologies (NAMs) into modern science, research and regulations. More information on the collaboration between the two societies will be announced at the ESTIV 2022 Congress in Barcelona-Sitges.

Related content

ESTIV: ERA4NAMs Survey – request for contribution

The ERA4NAMs Working Group on Education and Training is conducting a mapping exercise to identify existing training activities, educational resources, and capacity-building initiatives related to New Approach Methodologies (NAMs) across Europe and beyond.

The inaugural Liebsch & Spielmann Award presented at the ESTIV 2026 Congress

The European Society of Toxicology In Vitro (ESTIV) is proud to announce the recipients of the inaugural Liebsch & Spielmann Award for Contributions to the Validation of Alternative Methods.

In Memory of Dr. Alan M. Goldberg (1939–2026)

The European Society of Toxicology In Vitro (ESTIV) joins the international scientific community in mourning the loss of Dr. Alan M. Goldberg, who passed away on 9 June 2026 at the age of 86.

Silver Sponsor

React4Life

Corporate Members
Mattek in Vitro Life Science Laboratories

Communication partners

Memorandum of Understanding